For HER2-positive BC, defined as either IHC 3+ or IHC 2+ with HER2 amplification, neoadjuvant chemotherapy (NACT) plus neoadjuvant anti-HER2 therapy is an effective treatment option [4]. Here, ERBB2 is linked to breast cancer.